NO944247L - Anti-reseptormidler mot vitamin B12/transcobamin-II-reseptor - Google Patents

Anti-reseptormidler mot vitamin B12/transcobamin-II-reseptor

Info

Publication number
NO944247L
NO944247L NO944247A NO944247A NO944247L NO 944247 L NO944247 L NO 944247L NO 944247 A NO944247 A NO 944247A NO 944247 A NO944247 A NO 944247A NO 944247 L NO944247 L NO 944247L
Authority
NO
Norway
Prior art keywords
receptor
vitamin
transcobalamin
blocking agents
growth blocking
Prior art date
Application number
NO944247A
Other languages
English (en)
Norwegian (no)
Other versions
NO944247D0 (no
Inventor
Jr Alton Charles Morgan
Original Assignee
Receptagen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Receptagen Corp filed Critical Receptagen Corp
Publication of NO944247D0 publication Critical patent/NO944247D0/no
Publication of NO944247L publication Critical patent/NO944247L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO944247A 1992-05-08 1994-11-07 Anti-reseptormidler mot vitamin B12/transcobamin-II-reseptor NO944247L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88054092A 1992-05-08 1992-05-08
PCT/US1993/004341 WO1993023557A1 (en) 1992-05-08 1993-05-07 Anti-receptor agents to the vitamin b12/transcobalamin ii receptor

Publications (2)

Publication Number Publication Date
NO944247D0 NO944247D0 (no) 1994-11-07
NO944247L true NO944247L (no) 1995-01-09

Family

ID=25376514

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944247A NO944247L (no) 1992-05-08 1994-11-07 Anti-reseptormidler mot vitamin B12/transcobamin-II-reseptor

Country Status (11)

Country Link
US (1) US5688504A (de)
EP (1) EP0644948B1 (de)
JP (1) JPH07508174A (de)
KR (1) KR950701390A (de)
AT (1) ATE163679T1 (de)
AU (1) AU680822B2 (de)
CA (1) CA2135277C (de)
DE (1) DE69317282D1 (de)
NO (1) NO944247L (de)
NZ (1) NZ252559A (de)
WO (1) WO1993023557A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7416728B2 (en) 1992-05-08 2008-08-26 Kyto Biopharma, Inc. Growth blocking agents
CA2187346C (en) * 1994-04-08 2010-06-29 A. Charles Morgan, Jr. Receptor modulating agents and methods relating thereto
US5739287A (en) * 1994-04-08 1998-04-14 University Of Washington Biotinylated cobalamins
US5840880A (en) * 1994-04-08 1998-11-24 Receptagen Corporation Receptor modulating agents
US5869465A (en) * 1994-04-08 1999-02-09 Receptagen Corporation Methods of receptor modulation and uses therefor
AU3683395A (en) * 1994-09-13 1996-03-29 Receptagen Corporation Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites
EP1015475A1 (de) * 1995-10-19 2000-07-05 Receptagen Corporation Wirkstoffe zur modulation von vitaminen b12? -rezeptoren
WO1998051346A1 (en) * 1997-05-12 1998-11-19 Smithkline Beecham Corporation Human tumor necrosis factor receptor-like 2 (tr2) antibodies
US20020102258A1 (en) * 1997-05-12 2002-08-01 Smithkline Beecham Corporation Human tumor necrosis factor receptor-like 2 (TR2) antibodies
US6410245B1 (en) * 1998-04-01 2002-06-25 Affymax, Inc. Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
GB9820473D0 (en) * 1998-09-18 1998-11-11 Axis Biochemicals Asa Assay
US6492497B1 (en) * 1999-04-30 2002-12-10 Cambridge Antibody Technology Limited Specific binding members for TGFbeta1
JP2005508838A (ja) 2001-03-23 2005-04-07 アフトン コーポレーション 膵癌の組合せ治療
GB0109925D0 (en) * 2001-04-23 2001-06-13 Axis Shield Asa Method
US20090191232A1 (en) * 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
US20040047917A1 (en) * 2002-09-06 2004-03-11 Stephen Wilson Drug delivery and targeting with vitamin B12 conjugates
EP1794586B1 (de) 2004-09-22 2013-01-30 Cancer Advances, Inc., Monoklonale antikörper gegen progastrin
WO2007087266A2 (en) * 2006-01-23 2007-08-02 Errico Joseph P Methods and compositions of targeted drug development
CA2648718A1 (en) 2006-04-07 2007-10-18 The Research Foundation Of State University Of New York Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
US9044461B2 (en) 2006-04-07 2015-06-02 The Research Foundation Of State University Of New York Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
US9120858B2 (en) 2011-07-22 2015-09-01 The Research Foundation Of State University Of New York Antibodies to the B12-transcobalamin receptor
KR102772810B1 (ko) 2017-06-15 2025-02-28 캔서 어드밴시스 아이엔씨 종양 및 암에 대한 체액성 및 세포 면역을 유도하기 위한 조성물 및 방법
US12150978B2 (en) 2017-06-15 2024-11-26 Cancer Advances Inc. Compositions and methods for preventing tumors and cancer
WO2025219395A1 (en) 2024-04-16 2025-10-23 Chu D'angers Treatment of cancers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4332785A (en) * 1980-04-09 1982-06-01 University Patents, Inc. Immunoassay for measurement of reticulocytes, and immunoreactive reagents for use therein
JPS633262A (ja) * 1986-06-24 1988-01-08 Toshiba Corp 網状赤血球の分析方法及び装置

Also Published As

Publication number Publication date
ATE163679T1 (de) 1998-03-15
US5688504A (en) 1997-11-18
EP0644948B1 (de) 1998-03-04
AU680822B2 (en) 1997-08-14
CA2135277A1 (en) 1993-11-25
DE69317282D1 (de) 1998-04-09
CA2135277C (en) 2001-04-24
AU4239193A (en) 1993-12-13
EP0644948A1 (de) 1995-03-29
KR950701390A (ko) 1995-03-23
NZ252559A (en) 1996-10-28
JPH07508174A (ja) 1995-09-14
NO944247D0 (no) 1994-11-07
WO1993023557A1 (en) 1993-11-25

Similar Documents

Publication Publication Date Title
NO944247D0 (no) Anti-reseptormidler mot vitamin B12/transcobamin-II-reseptor
FI960567A0 (fi) Monoklonaalinen vasta-aine, joka indusoi apoptoosin
DK0724456T3 (da) CD40-Antistoffer
AR001413A1 (es) Compuestos triciclicos de carbamato, utiles para la inhibición de la función de la proteina g y paratratamiento de enfermedades proliferativas.
AU6914798A (en) Compounds and methods for inhibiting the interaction between alpha-catenin and beta-catenin
EA199700280A1 (ru) Ингибиторы протеинкиназы с
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
YU28897A (sh) Biciklicno kondenzovani piridini
DK0689426T3 (da) Terapeutisk middel til behandling af melanomer
DK0802924T3 (da) Lægemiddel til forlænget immunsuppression og eliminering af tumorceller
AU7657387A (en) Apoprotein b-100 specific monoclonal antibodies
DE59203128D1 (de) Abbrandträger zum abbrennen von explosivstoffen.
AU3683395A (en) Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites
TR199900943T2 (xx) Pirimidin t�revlerinin haz�rlanma prosesi.
FR2707171B1 (fr) Pellicule adhésive pour bandage et bandage adhésif utilisant cette pellicule.
WO2002042318A3 (en) Transcobalamin receptor binding conjugates for neutron capture therapy
NO891713D0 (no) Monoklonale antistoffer til vevplasminogenaktivator (t-pa)
FR2693561B1 (fr) Source de lumière polarisée et rétroprojecteur utilisant cette source.
PT584368E (pt) Utilizacao e processo para a producao de um inibidor de metasteses e um inibidor de adesao celular contendo respectivamente um anticorpo
KR940000965U (ko) 정량 눈새김 연료운반통
UA8309A (uk) Система виявлення лазерного опромінювання
DK240388D0 (da) Paahaengsvogn til transport af skiftelad
KR970706308A (ko) 비타민 B_12/트랜스코발아맨 Ⅱ 수용체 및 결합 부위에 대한 항-수용체 및 성장차단제(Anti-receptor and growth blocking agents to the vitamin B_12/transcobalamin Ⅱ receptor and binding sites)
DK87293D0 (da) Soenderdelingsapparat til selektiv soenderdeling af materialer med forskellig brudstyrke
DE69324928D1 (de) Monoklonaler antikörper